Case Report
Accepted on 11 Dec 2025
Pathological Complete Response Yet Early Brain Relapse in HER2-Positive Breast Cancer: A Case-Based Review
in Cancer Immunity and Immunotherapy
- 213 views
Case Report
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Editorial
Accepted on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Systematic Review
Accepted on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 11 Dec 2025
in Nutritional Immunology
Original Research
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 11 Dec 2025
in Vaccines and Molecular Therapeutics
Correction
Published on 11 Dec 2025
in Primary Immunodeficiencies
Original Research
Published on 11 Dec 2025
in Alloimmunity and Transplantation
Original Research
Published on 11 Dec 2025
in Comparative Immunology
Review
Published on 11 Dec 2025
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 11 Dec 2025
in Inflammation
Brief Research Report
Published on 11 Dec 2025
in Molecular Innate Immunity
Original Research
Published on 11 Dec 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 11 Dec 2025
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 11 Dec 2025
in Inflammation
Original Research
Published on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Mini Review
Published on 11 Dec 2025
in Viral Immunology
Original Research
Published on 11 Dec 2025
in Cancer Immunity and Immunotherapy